Clinical Trials Directory

Trials / Completed

CompletedNCT06415799

OM2 Abbreviated Sensor Verification

Verification of Investigational Pulse Oximetry Devices With the Abbreviated Sensor Line in Adult Volunteers

Status
Completed
Phase
Study type
Observational
Enrollment
28 (actual)
Sponsor
Medtronic - MITG · Industry
Sex
All
Age
18 Years – 50 Years
Healthy volunteers
Accepted

Summary

The verification of an investigational pulse oximetry board to verify pulse rate and saturation accuracy over a specified saturation range in diverse populations.

Detailed description

To verify the SpO2 and pulse rate accuracy in comparison to reference-standard blood measurements. To achieve paired observations of SpO2 and SaO2 values over the specified SpO2 accuracy range of the prototype pulse oximeter on a group of healthy adult volunteers. The fraction of inspired oxygen (FiO2) delivered to test subjects is varied to achieve a series of targeted steady-state saturation periods. In this study, the investigational pulse oximetry PCBA system saturation measurements will be compared to saturation measurements made by a multi-wavelength CO-oximeter, taken from arterial blood samples from a diverse pool of healthy human subjects.

Conditions

Timeline

Start date
2024-02-11
Primary completion
2024-02-22
Completion
2024-02-22
First posted
2024-05-16
Last updated
2025-07-28

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT06415799. Inclusion in this directory is not an endorsement.

OM2 Abbreviated Sensor Verification (NCT06415799) · Clinical Trials Directory